Immediate Impact
5 by Nobel laureates 95 standout
Citing Papers
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
2025 Standout
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
Works of Grit Andersen being referenced
Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non‐alcoholic fatty liver disease assessed by magnetic resonance imaging
2021 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Grit Andersen | 219 | 124 | 75 | 110 | 21 | 320 | |
| Lilia M. Jiménez-Ceja | 142 | 114 | 95 | 38 | 13 | 290 | |
| A J Scheen | 175 | 86 | 148 | 60 | 22 | 346 | |
| Yangliang Ye | 97 | 93 | 145 | 49 | 23 | 340 | |
| Carolin Lackner | 73 | 54 | 74 | 110 | 13 | 300 | |
| Xunjun Xiao | 49 | 177 | 82 | 46 | 20 | 298 | |
| Leo P. Krall | 187 | 64 | 69 | 35 | 23 | 332 | |
| Sohrab Halalkhor | 81 | 72 | 77 | 49 | 24 | 321 | |
| Xuejun Li | 97 | 42 | 71 | 155 | 30 | 313 | |
| Takehiko Idé | 185 | 148 | 82 | 30 | 21 | 355 | |
| Sandeep Thareja | 56 | 77 | 51 | 208 | 22 | 352 |
All Works
Login with ORCID to disown or claim papers
Loading papers...